Literature DB >> 9496378

Complex behavior of marine animal tissue extracts in the competitive binding assay of brevetoxins with rat brain synaptosomes.

P L Whitney1, J A Delgado, D G Baden.   

Abstract

Brevetoxins are produced by the marine dinoflagellate Ptychodiscus brevis, an organism linked to red tide outbreaks, and the accompanying toxicity to marine animals and to neurotoxic shellfish poisoning in humans. Brevetoxins bind with high affinity to voltage-sensitive sodium channels and cause increased sodium ion conductance and nerve cell depolarization. The brevetoxin competitive binding assay with tritium-labeled brevetoxin 3 (3H-PbTx-3) and rat brain synaptosomes is a sensitive and specific assay for pure brevetoxins. Here we report that extracts of manatee, turtle, fish, and clam tissues contain components that interfere with the assay by cooperative, noncompetitive inhibition of 3H-PbTx-3 specific binding and increased nonspecific binding to synaptosomes. By determining the "apparent" toxin concentration ("[Toxin]") in the extract at several assay concentrations, a reasonable correction for the complex inhibition could be made using a semilog plot to extrapolate [Toxin] to zero extract concentration to obtain [Toxin]0. Spiking 4 extracts with 60 nM PbTx-3 caused [Toxin]0 to increase by 41 +/- 8 nM, indicating that the noncompetitive components did not prevent the assay of toxin but did reduce the accuracy of the result. Fourfold repetition of the assay of 4 samples gave standard deviations of 25 to 60% of the value of [Toxin]0, so the error can be fairly large, especially for samples with little toxin. Purification of an extract with a 1 g sample prep column of C-18 decreased the complex inhibition by about 3-fold but did not eliminate interference in the assay.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9496378     DOI: 10.1002/nt.4

Source DB:  PubMed          Journal:  Nat Toxins        ISSN: 1056-9014


  4 in total

1.  Literature Review of Florida Red Tide: Implications for Human Health Effects.

Authors:  Barbara Kirkpatrick; Lora E Fleming; Dominick Squicciarini; Lorrie C Backer; Richard Clark; William Abraham; Janet Benson; Yung Sung Cheng; David Johnson; Richard Pierce; Julia Zaias; Gregory D Bossart; Daniel G Baden
Journal:  Harmful Algae       Date:  2004-04-01       Impact factor: 4.273

Review 2.  Update on methodologies available for ciguatoxin determination: perspectives to confront the onset of ciguatera fish poisoning in Europe.

Authors:  Amandine Caillaud; Pablo de la Iglesia; H Taiana Darius; Serge Pauillac; Katerina Aligizaki; Santiago Fraga; Mireille Chinain; Jorge Diogène
Journal:  Mar Drugs       Date:  2010-06-14       Impact factor: 5.118

Review 3.  Potential threats posed by new or emerging marine biotoxins in UK waters and examination of detection methodology used in their control: brevetoxins.

Authors:  Andrew D Turner; Cowan Higgins; Keith Davidson; Andrea Veszelovszki; Daniel Payne; James Hungerford; Wendy Higman
Journal:  Mar Drugs       Date:  2015-03-12       Impact factor: 5.118

4.  Chemiluminescent Receptor Binding Assay for Ciguatoxins and Brevetoxins Using Acridinium Brevetoxin-B2.

Authors:  Kazuya Murata; Takeshi Yasumoto
Journal:  Toxins (Basel)       Date:  2019-10-09       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.